TABLE 2.

MiSH and SCORAD of the 18 AD patients in the BCP2 and B7U treatment groups, both prior to treatment and posttreatment

Sample ID	Type	MiSH at:		SCORAD at:
		Baseline	After treatment	Baseline	After treatment
1039	I	0.06	17.64	33.40	6.62
1069	I	0.14	19.88	55.80	36.50
1072	I	0.10	25.06	33.57	10.65
1052	I	0.22	25.84	35.12	22.82
1050	I	2.60	30.62	73.00	33.50
1001	I	2.48	46.08	41.83	16.52
1024	I	0.02	45.06	42.91	47.24
1056	II	30.54	12.66	48.81	41.48
1080	II	60.62	59.42	28.30	10.35
1089	II	34.20	35.88	28.88	20.31
1005	II	26.90	30.84	65.75	25.29
1070	II	41.58	62.14	13.20	1.95
1030	II	38.68	59.60	46.39	44.14
1060	II	35.04	59.46	44.82	20.62
1064	II	15.38	41.04	38.55	7.79
1077	II	30.16	65.84	31.20	19.94
1078	II	20.90	60.92	42.24	13.31